Franciscan Health Indianapolis
Indianapolis, Indiana, United States
Hospital in Indianapolis, Indiana
8111 S Emerson Ave, Indianapolis, IN 46237
About Franciscan Health Indianapolis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
56
SWOG Cancer Research Network
26
Alliance for Clinical Trials in Oncology
15
Eli Lilly and Company
6
NRG Oncology
6
Abbott Medical Devices
5
Boston Scientific Corporation
4
Bristol-Myers Squibb
4
Gynecologic Oncology Group
4
Jazz Pharmaceuticals
4
Radiation Therapy Oncology Group
4
Clinical Trials at Franciscan Health Indianapolis
During the past decade, Franciscan Health Indianapolis conducted 93 clinical trials. In the 10-year time frame, 93 clinical trials started and 82 clinical trials were completed, i.e. on
average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 42 clinical trials were completed. i.e. 182.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
1999-04-01
2011-02-01
Completed
605
Combination Chemotherapy in Treating Patients With Bladder Cancer
2004-03-01
2009-04-01
Completed
42
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
2001-09-01
2012-11-01
Completed
183
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
2002-10-01
2008-10-01
Completed
67
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
2002-06-01
2015-10-01
Completed
147
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
2002-07-01
2022-05-20
Completed
743
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Franciscan Health Indianapolis" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 26 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "NRG Oncology"
with 6 trials sponsored. Other sponsors include 89 different institutions and
companies that sponsored additional 65 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Franciscan Health Indianapolis"
#1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 62 different institutions and companies that were
collaborators in the rest 62 trials.
Clinical Trials Conditions at Franciscan Health Indianapolis
According to Clinical.Site data, the most researched conditions in "Franciscan Health Indianapolis" are
"Breast Cancer" (12 trials), "Coronary Artery Disease" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials) and "Multiple Myeloma" (5 trials). Many other conditions were trialed in "Franciscan Health Indianapolis" in a lesser frequency.
Clinical Trials Intervention Types at Franciscan Health Indianapolis
Most popular intervention types in "Franciscan Health Indianapolis" are "Drug" (146 trials), "Other" (86 trials), "Biological" (57 trials), "Procedure" (35 trials) and "Device" (31 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (30 trials), "Paclitaxel" (19 trials), "Placebo" (17 trials) and "Carboplatin" (16 trials). Other intervention names were less common.
Clinical Trials Genders at Franciscan Health Indianapolis
The vast majority of trials in "Franciscan Health Indianapolis" are
172 trials for "All" genders, 30 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Franciscan Health Indianapolis
Currently, there are NaN active trials in "Franciscan Health Indianapolis".
undefined are not yet recruiting,
31 are recruiting,
77 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 73 completed trials in Franciscan Health Indianapolis,
1 suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Franciscan Health Indianapolis, 7 "Phase 1"
clinical trials were conducted, 64 "Phase 2" clinical
trials and 106 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 20 trials that are defined as “Not Applicable".